Open Site Navigation




ActiGraft® System, a patented proprietary technology was developed by RedDress®, a privately held company based in Israel. Their goal is to develop more effective, natural and economically viable treatments for Chronic Wounds. The first of its kind technology enables health care providers to produce in real time – an in vitro blood clot from a patient’s whole blood.  Once applied the blood clot serves as a protective covering and supports wound healing processes which naturally occur in the patient’s body.